Aillis Launches 'Evidence Finder' – An AI-Powered Evidence Search Tool for Physicians
Aillis, Inc. has introduced 'Evidence Finder,' a tool for doctors that combines PubMed search results with AI-generated answers. It ensures high reliability through transparent citations and an automated verification feature to prevent AI hallucinations.
📋 Article Processing Timeline
- 📰 Published: May 19, 2026 at 23:45
- 🔍 Collected: May 19, 2026 at 15:32
- 🤖 AI Analyzed: May 19, 2026 at 15:32 (0 min after Collected)
Aillis, Inc. (Headquarters: Chiyoda-ku, Tokyo; CEO: Sho Okiyama) launched 'Evidence Finder,' an AI-based evidence search function for physicians, on May 19, 2026.
'Evidence Finder' is designed to prioritize the transparency of citations and mitigate AI hallucinations. In response to a physician's query, the system integrates PubMed literature searches with AI answer generation, presenting results with clearly marked references. It features a standard 'Verify' function that automatically confirms the existence of cited papers, providing a streamlined path for doctors to reach primary sources as quickly as possible.
Under the mission 'Building an open healthcare environment through co-creation,' Aillis developed this tool to address the challenge of efficiently accessing the latest medical evidence. While the service is not classified as a medical device and is intended for general medical information purposes only, the company plans to release additional features continuously based on professional feedback.
### About Aillis, Inc.
Founded in November 2017, Aillis is a healthcare AI startup led by CEO Okiyama, an active physician. The company consists of professionals from diverse backgrounds, including healthcare, government administration (Ministry of Health, Labour and Welfare, etc.), and data science. They specialize in developing AI medical devices that digitize expert clinical skills using machine learning technologies.
'Evidence Finder' is designed to prioritize the transparency of citations and mitigate AI hallucinations. In response to a physician's query, the system integrates PubMed literature searches with AI answer generation, presenting results with clearly marked references. It features a standard 'Verify' function that automatically confirms the existence of cited papers, providing a streamlined path for doctors to reach primary sources as quickly as possible.
Under the mission 'Building an open healthcare environment through co-creation,' Aillis developed this tool to address the challenge of efficiently accessing the latest medical evidence. While the service is not classified as a medical device and is intended for general medical information purposes only, the company plans to release additional features continuously based on professional feedback.
### About Aillis, Inc.
Founded in November 2017, Aillis is a healthcare AI startup led by CEO Okiyama, an active physician. The company consists of professionals from diverse backgrounds, including healthcare, government administration (Ministry of Health, Labour and Welfare, etc.), and data science. They specialize in developing AI medical devices that digitize expert clinical skills using machine learning technologies.
FAQ
How does Evidence Finder ensure the accuracy of its search results?
It features a 'Verify' function that automatically checks the existence of cited literature, preventing AI hallucinations and ensuring factual grounding.
Is this tool intended for use in actual patient diagnosis?
No, it is not a medical device. It is designed to provide general medical information and assist physicians in finding academic evidence efficiently.
Who developed Evidence Finder?
It was developed by Aillis, Inc., a Japanese medical AI startup led by an active physician and comprising specialists in AI and medical regulatory affairs.